Here, we report the development of a subunit COVID-19 vaccine based on recombinant SARS-CoV-2 RBD proteins produced in yeast49,50 that are displayed on influenza virosomes acting as antigen carriers51–53, together with membrane anchored 3M-052 as TLR7/8 agonist. Here, TLR7 is linked to influenza.